Erik Quan, MD

Erik is a therapist and study physician for the psilocybin for depression clinical trial and will be working on the upcoming CBD for chronic pain study. He is a NYU psychiatry resident keen on exploring psychedelics in the treatment of addiction. His other interests include the role of music in psychedelic therapy as well as how to make these medicines accessible and equitable.